Further to my post, it's important to note that the company has not previously engaged a Contract Manufacturing Organisation (CMO). They previously attempted to submit for TGA using a variety of external Australian consultants alongside French manufacturer Biotem. This time around, they are essentially engaging a 'one stop shop', based in the US, to complete the whole task through to the regulatory IVDR/TGA application. I believe the Board will have selected an experienced CMO, with a proven record of success, of which there are many in the US, bearing in mind that Colostat is a simple ELISA immunoassay test.
An interesting aside is that the ELISA test diagnostic market is forecast to hit US$4 billion by 2030 (worth US $2.35 billion in 2022).
- Forums
- ASX - By Stock
- RHY
- Future Announcements
Future Announcements, page-3
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
-0.003(5.00%) |
Mkt cap ! $13.92M |
Open | High | Low | Value | Volume |
6.0¢ | 6.0¢ | 5.6¢ | $9.338K | 160.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 32 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12000 | 0.057 |
2 | 26855 | 0.056 |
1 | 54545 | 0.055 |
1 | 68500 | 0.051 |
1 | 59995 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 32 | 1 |
0.060 | 15763 | 1 |
0.061 | 70899 | 1 |
0.062 | 144742 | 1 |
0.063 | 34 | 1 |
Last trade - 11.20am 10/07/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online